Published

Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: American journal of therapeutics
Date: 2024-01-01
Source: PubMed
DOI: 10.1097/mjt.0000000000001724
PubMed: 38518269

Authors

Tabaac BJ Shinozuka K Arenas A Beutler BD Cherian K Evans VD Fasano C Muir OS

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Addiction End-of-Life Distress Headache / Migraine Pharmacology Receptor Pharmacology Consciousness Clinical Trial Review Article Treatment-Resistant Depression Healthcare Workers Safety Adverse Events Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Prevalence and Correlates of Past-Year Psilocybin Use in the United States2026-04-22 Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.2024-01-01

Related papers

From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10 Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric DisordersPsychiatry and Clinical Psychopharmacology · 2026-03-30 Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15 Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.Journal of clinical psychopharmacology · 2026-01-01 Psychedelics, entactogens and psychoplastogens for depression and related disorders.British journal of pharmacology · 2026-07-01 Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.British journal of pharmacology · 2026-07-01 Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’Behavioural Pharmacology · 2026-05-06 Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.Journal of psychopharmacology (Oxford, England) · 2026-01-01